[size=0.875]ARTICLES[color=var(--theme-font-color,#fff)][size=0.875]|[color=var(--theme-font-color,#fff)][size=0.875]VOLUME 11, ISSUE 5[color=var(--theme-font-color,#fff)][size=0.875][color=var(--theme-font-color,#fff)][size=0.875], [color=var(--theme-font-color,#fff)][size=0.875]E358-E367, [color=var(--theme-font-color,#fff)][size=0.875]MAY 2024[color=var(--theme-font-color,#fff)][color=var(--theme-font-color,#fff)]Download Full Issue
- [color=var(--theme-font-color,#fff)][size=0.875][size=1.6]Purchase
- [color=var(--theme-font-color,#fff)][size=0.875][size=1.6]Subscribe
[color=var(--theme-font-color,#fff)] [size=0.875][size=1.6]Save
[color=var(--theme-font-color,#fff)] [size=0.875][size=1.6]Share
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study[size=1.38]
[color=var(--theme-font-color,#fff)]George Hucks, MD
[color=var(--theme-font-color,#fff)]Marcie L Riches, MD
[color=var(--theme-font-color,#fff)]Prof Anastasia Ivanova, PhD
[color=var(--theme-font-color,#fff)]Dominic T Moore, MPH
[color=var(--theme-font-color,#fff)]Prof Thomas C Shea, MD
et al.[color=var(--theme-font-color,#fff)]Show all authors
Published:March 28, 2024DOI:[color=var(--theme-font-color,#fff)]https://doi.org/10.1016/S2352-3026(24)00064-4
|
Closed
10
Release of a ubiquitin brake activates OsCERK1-triggered immunity in rice
